These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7939446)

  • 1. Natural history of carcinoma in situ of the urinary bladder.
    Wolf H; Melsen F; Pedersen SE; Nielsen KT
    Scand J Urol Nephrol Suppl; 1994; 157():147-51. PubMed ID: 7939446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term efficacy of intravesical bacillus Calmette-Guerin for carcinoma in situ: relationship of progression to histological response and p53 nuclear accumulation.
    Ovesen H; Horn T; Steven K
    J Urol; 1997 May; 157(5):1655-9. PubMed ID: 9112499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival of patients with carcinoma in situ of the urinary bladder.
    Cheng L; Cheville JC; Neumann RM; Leibovich BC; Egan KS; Spotts BE; Bostwick DG
    Cancer; 1999 Jun; 85(11):2469-74. PubMed ID: 10357420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term efficacy of maintenance bacillus Calmette-Guérin versus maintenance mitomycin C instillation therapy in frequently recurrent TaT1 tumours without carcinoma in situ: a subgroup analysis of the prospective, randomised FinnBladder I study with a 20-year follow-up.
    Järvinen R; Kaasinen E; Sankila A; Rintala E;
    Eur Urol; 2009 Aug; 56(2):260-5. PubMed ID: 19395154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long term follow-up of intravesical Bacillus Calmette-Guerin for the treatment of bladder transitional cell carcinoma.
    Leblanc B; Duclos AJ; Bénard F; Valiquette L; Paquin JM; Lapointe S; Mauffette F; Pharand D; Faucher R; Drouin G; Perreault JP
    Can J Urol; 2000 Feb; 7(1):944-8. PubMed ID: 11121250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes of bacillus Calmette-Guérin instillation therapy for carcinoma in situ of urinary bladder.
    Takenaka A; Yamada Y; Miyake H; Hara I; Fujisawa M
    Int J Urol; 2008 Apr; 15(4):309-13. PubMed ID: 18380817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bladder sparing approach for initial T1G3 bladder cancer: Do multifocality, size of tumor or concomitant carcinoma in situ matter? A long-term analysis of 132 patients.
    Denzinger S; Otto W; Fritsche HM; Roessler W; Wieland WF; Hartmann A; Burger M
    Int J Urol; 2007 Nov; 14(11):995-9; discussion 999. PubMed ID: 17956523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term effects of bacille Calmette-Guérin perfusion therapy for treatment of transitional cell carcinoma in situ of upper urinary tract.
    Hayashida Y; Nomata K; Noguchi M; Eguchi J; Koga S; Yamashita S; Hayashi M; Kanatake H
    Urology; 2004 Jun; 63(6):1084-8. PubMed ID: 15183955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study.
    Lamm DL; Blumenstein BA; Crissman JD; Montie JE; Gottesman JE; Lowe BA; Sarosdy MF; Bohl RD; Grossman HB; Beck TM; Leimert JT; Crawford ED
    J Urol; 2000 Apr; 163(4):1124-9. PubMed ID: 10737480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases.
    Guo CC; Fine SW; Epstein JI
    Am J Surg Pathol; 2006 Jul; 30(7):883-91. PubMed ID: 16819332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low dose bacillus Calmette-Guerin for carcinoma in situ of the bladder: long-term results.
    Losa A; Hurle R; Lembo A
    J Urol; 2000 Jan; 163(1):68-71; discussion 71-2. PubMed ID: 10604316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The natural history of bladder carcinoma in situ after initial response to bacillus Calmette-Gúerin immunotherapy.
    Gofrit ON; Pode D; Pizov G; Zorn KC; Katz R; Duvdevani M; Shapiro A
    Urol Oncol; 2009; 27(3):258-62. PubMed ID: 18440839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flat intraepithelial lesions of the urinary bladder.
    Cheng L; Cheville JC; Neumann RM; Bostwick DG
    Cancer; 2000 Feb; 88(3):625-31. PubMed ID: 10649257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of the ImmunoCyt/uCyt+ test in the detection and follow-up of carcinoma in situ of the urinary bladder.
    Mian C; Lodde M; Comploj E; Palermo S; Mian M; Maier K; Pycha A
    Anticancer Res; 2005; 25(5):3641-4. PubMed ID: 16101194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrence, progression and success in stage Ta grade 3 bladder tumors treated with low dose bacillus Calmette-Guerin instillations.
    Lebret T; Bohin D; Kassardjian Z; Herve JM; Molinie V; Barre P; Lugagne PM; Botto H
    J Urol; 2000 Jan; 163(1):63-7. PubMed ID: 10604315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The treated natural history of high risk superficial bladder cancer: 15-year outcome.
    Cookson MS; Herr HW; Zhang ZF; Soloway S; Sogani PC; Fair WR
    J Urol; 1997 Jul; 158(1):62-7. PubMed ID: 9186324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intravesical instillations of BCG and bladder carcinoma in situ].
    Haab F; Dauge MC; Delmas V; Boccon-Gibod L
    Prog Urol; 1993 Dec; 3(6):988-94; discussion 992-3. PubMed ID: 8305942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical observation on in situ carcinoma of the bladder and related conditions].
    Matsuda M; Tada Y; Nakano E; Fujioka H; Osafune M; Takaha M; Sonoda T
    Hinyokika Kiyo; 1985 Feb; 31(2):249-55. PubMed ID: 4013943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of histopathological tumour growth patterns at the invasion front of T1G3 urothelial carcinoma of the bladder.
    Denzinger S; Burger M; Fritsche HM; Bertz S; Hofstädter F; Wieland WF; Hartmann A; Otto W
    Scand J Urol Nephrol; 2009; 43(4):282-7. PubMed ID: 19382004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does photodynamic transurethral resection of bladder tumour improve the outcome of initial T1 high-grade bladder cancer? A long-term follow-up of a randomized study.
    Denzinger S; Wieland WF; Otto W; Filbeck T; Knuechel R; Burger M
    BJU Int; 2008 Mar; 101(5):566-9. PubMed ID: 17986289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.